CA1162189A - Dibenzoxazepine derivative, process for preparing the same, and pharmaceutical composition comprising the same - Google Patents

Dibenzoxazepine derivative, process for preparing the same, and pharmaceutical composition comprising the same

Info

Publication number
CA1162189A
CA1162189A CA000378457A CA378457A CA1162189A CA 1162189 A CA1162189 A CA 1162189A CA 000378457 A CA000378457 A CA 000378457A CA 378457 A CA378457 A CA 378457A CA 1162189 A CA1162189 A CA 1162189A
Authority
CA
Canada
Prior art keywords
compound
formula
ethyl
process according
oxazepine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000378457A
Other languages
English (en)
French (fr)
Inventor
Hiroshi Matsushita
Shun-Ichi Hata
Yukifumi Noda
Hiroshi Nakakimura
Masuo Koizumi
Tomohiro Neichi
Yasushi Murakami
Kazuo Sasahara
Masamitsu Honda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of CA1162189A publication Critical patent/CA1162189A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20—[b, f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA000378457A 1980-05-28 1981-05-27 Dibenzoxazepine derivative, process for preparing the same, and pharmaceutical composition comprising the same Expired CA1162189A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7017680A JPS56166180A (en) 1980-05-28 1980-05-28 Dibenzoxazepine derivative and its preparation
JP70176/1980 1980-05-28

Publications (1)

Publication Number Publication Date
CA1162189A true CA1162189A (en) 1984-02-14

Family

ID=13423954

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000378457A Expired CA1162189A (en) 1980-05-28 1981-05-27 Dibenzoxazepine derivative, process for preparing the same, and pharmaceutical composition comprising the same

Country Status (11)

Country Link
US (1) US4435391A (enExample)
EP (1) EP0040860B1 (enExample)
JP (1) JPS56166180A (enExample)
KR (1) KR850000212B1 (enExample)
AT (1) ATE6645T1 (enExample)
CA (1) CA1162189A (enExample)
DE (1) DE3162614D1 (enExample)
HU (1) HU183456B (enExample)
IL (1) IL62894A (enExample)
MX (1) MX157054A (enExample)
ZA (1) ZA813385B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240721A3 (en) * 1986-03-12 1991-01-02 Chugai Seiyaku Kabushiki Kaisha Therapeutic agent for the treatment of peripheral circulatory disorders
WO1996010021A1 (en) * 1994-09-28 1996-04-04 Nippon Suisan Kaisha, Ltd. Novel antioxidant tricyclic fused heterocyclic compound
WO1996033983A1 (en) * 1995-04-25 1996-10-31 Daiichi Radioisotope Laboratories, Ltd. Dibenzoxazepine n-oxide derivatives and drug containing the same as the active ingredient
JP4582366B2 (ja) * 1998-11-30 2010-11-17 東レ・ファインケミカル株式会社 ピロリジン誘導体の製造法
US7550499B2 (en) * 2004-05-12 2009-06-23 Bristol-Myers Squibb Company Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
EP1954696B1 (en) * 2005-01-19 2011-02-23 Bristol-Myers Squibb Company 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
WO2007002634A1 (en) * 2005-06-27 2007-01-04 Bristol-Myers Squibb Company Carbocycle and heterocycle antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
ES2352796T3 (es) * 2005-06-27 2011-02-23 Bristol-Myers Squibb Company Antagonistas cíclicos unidos a c del receptor p2y1 útiles en el tratamiento de afecciones trombóticas.
ES2360818T3 (es) * 2005-06-27 2011-06-09 Bristol-Myers Squibb Company Miméticos de urea lineal antagonistas del receptor p2y, útiles en el tratamiento de afecciones trombóticas.
EP1896466B1 (en) * 2005-06-27 2011-04-13 Bristol-Myers Squibb Company N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
WO2007047737A1 (en) * 2005-10-17 2007-04-26 Acadia Pharmaceuticals Inc. Cb-1 modulating compounds and their use
US20080090805A1 (en) * 2005-10-17 2008-04-17 Acadia Pharmaceuticals Inc. Cb-1 modulating compounds and their use
US7960569B2 (en) * 2006-10-17 2011-06-14 Bristol-Myers Squibb Company Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
ES2535730T3 (es) * 2007-12-05 2015-05-14 Janssen Pharmaceutica, N.V. Agonistas TRPA1 de dibenzoazepinas y dibenzooxazepinas
WO2019173761A1 (en) * 2018-03-09 2019-09-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH473141A (de) 1965-12-30 1969-05-31 Wander Ag Dr A Verfahren zur Herstellung 11-aminoalkylierter Dibenz(b,f)-1,4-oxazepine und Dibenzo(b,f)-1,4-thiazepine
US3646009A (en) 1967-03-15 1972-02-29 Boehringer & Soehne Gmbh Anti-diabetically active sulfonyl-semicarbazides
US3458516A (en) 1968-02-16 1969-07-29 American Cyanamid Co 11-(piperazinyl)dibenz(b,f)(1,4)oxazepines and analogous thiazepines
US3676460A (en) 1969-03-28 1972-07-11 Sumitomo Chemical Co Benzoxazepine derivatives
JPS5576869A (en) * 1978-12-06 1980-06-10 Chugai Pharmaceut Co Ltd Dibenzoxazepine derivative and its preparation

Also Published As

Publication number Publication date
KR850000212B1 (ko) 1985-03-06
ZA813385B (en) 1982-06-30
US4435391A (en) 1984-03-06
HU183456B (en) 1984-05-28
DE3162614D1 (en) 1984-04-19
KR830006249A (ko) 1983-09-20
JPH0223550B2 (enExample) 1990-05-24
EP0040860A1 (en) 1981-12-02
ATE6645T1 (de) 1984-03-15
MX157054A (es) 1988-10-24
IL62894A (en) 1984-10-31
EP0040860B1 (en) 1984-03-14
IL62894A0 (en) 1981-07-31
JPS56166180A (en) 1981-12-21

Similar Documents

Publication Publication Date Title
CA1162189A (en) Dibenzoxazepine derivative, process for preparing the same, and pharmaceutical composition comprising the same
CA1087205A (en) 2-amino-3-(5-and 6-)benzoylphenylacetic acids, esters and metal salts thereof
US3850941A (en) 2-alkyl-3-acylpyrazolo(1,5-a)pyridines
US4352803A (en) Novel naphthyridine derivatives, intermediates thereof, processes for preparation thereof, and use thereof
US4840951A (en) Novel naphthalene derivative
JPS6089474A (ja) モルフイナン誘導体，その製造方法，及び該化合物を含有する抗腫瘍剤
EP0508740A1 (en) Thiazolidinedione derivatives, their production and their use
GB1569039A (en) Derivatives of 10,11-dihydrobenzo(4,5)-cyclohepta(1,2-b)-pyrazolo(4,3-e)-pyridine-5(1h)one
NO142221B (no) Analogifremgangsmaate ved fremstilling av antibakterielt virksomme piperazinderivater
US4144337A (en) 1,4-Substituted piperazinyl derivatives useful as psychostimulants
US4049653A (en) Heterocyclic esters of alkylphenyl benzopyrans
NZ203519A (en) 2(1h)-pyridinone derivatives and pharmaceutical compositions
US3929812A (en) Derivatives of 1H-triazolo {8 4,5-c{9 pyridine-7-carboxylic acids and esters
GB2062637A (en) Imidazolylethoxy derivatives of quinoline-2-or 4-methanols
US3621026A (en) Blood-sugar-lowering sulfonylamino pyrimidines
PL130510B1 (en) Process for preparing novel condensed derivatives of as-triazine
US3723466A (en) Tricyclic compounds
US4558134A (en) Certain phenoxy-pyridine-carbonitriles having antiviral activity
US3565899A (en) Oxy-substituted benzo quinolizinium compounds
US4843085A (en) Pyridine derivatives, process for production thereof and pharmaceutical compositions useful as anti-arhytmics
US3055890A (en) Phenthiazine derivatives
CA1036605A (en) Amino derivatives of pyrido (3,4-b) pyrazine carboxylic acids and esters
US3635962A (en) 4 - bis-morpholino- and 2
JPS6038383B2 (ja) 新規１−〔３−（３，４，５−トリメトキシフェノキシ）−２−ヒドロキシ−プロピル〕−４−アリ−ル−ピペラジン誘導体及びその製造法
US4677109A (en) 1-(6-(2'-substiuted-5', 6', 7', 8'-tetrahydro-4',-oxo-quinazolino))-3-4-dihydro-6,7-disubstituted-isoquinoline derivatives and pharmaceutical compostions containing them

Legal Events

Date Code Title Description
MKEX Expiry